HIV Integrase Inhibitors
    3.
    发明申请
    HIV Integrase Inhibitors 有权
    HIV整合酶抑制剂

    公开(公告)号:US20090253681A1

    公开(公告)日:2009-10-08

    申请号:US11887305

    申请日:2006-03-22

    摘要: Compounds of Formula I are inhibitors of FHV integrase and inhibitors of FHV replication (I), wherein m, n, X, R1, R2, R3, R4, R5, R6, R7; R8, R9 and R10 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HTV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HTV infection and ADDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 式I化合物是FHV整合酶的抑制剂和FHV复制抑制剂(I),其中m,n,X,R 1,R 2,R 3,R 4,R 5,R 6,R 7; R8,R9和R10在本文中定义。 该化合物可用于预防或治疗HTV感染以及预防,治疗或延迟AIDS发病。 该化合物用于抗HTV感染和ADDS作为化合物本身或以药学上可接受的盐的形式。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。

    Hiv integrase inhibitors
    5.
    发明申请
    Hiv integrase inhibitors 审中-公开
    Hiv整合酶抑制剂

    公开(公告)号:US20070161639A1

    公开(公告)日:2007-07-12

    申请号:US10587601

    申请日:2005-03-01

    摘要: Pyridopyrazine- and pyrimidopyrazine-dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dihydroxypyridine carboxamides are of Formula (I); wherein G, Q, bond a, R5, R6 and R7 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 吡啶并吡嗪和嘧啶并吡嗪二酮化合物是HIV整合酶和HIV复制抑制剂的抑制剂。 在一个实施方案中,二羟基吡啶甲酰胺具有式(I); 其中G,Q,键a,R 5,R 6和R 7均在本文中定义。 这些化合物可用于预防和治疗艾滋病毒感染以及预防,延迟艾滋病的发病和治疗。 这些化合物用作抗感染和艾滋病作为化合物本身或以药学上可接受的盐的形式。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。

    Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
    7.
    发明授权
    Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors 有权
    可用作HIV整合酶抑制剂的取代的嘧啶并[1,2-a]吖庚因

    公开(公告)号:US07414045B2

    公开(公告)日:2008-08-19

    申请号:US10540449

    申请日:2003-12-18

    CPC分类号: C07D487/04 C07D471/04

    摘要: Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R1, R3, R4, R12, R14, R16, R30, R32, R34 and R36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 四氢-4H-吡啶并[1,2-a]嘧啶和式(A)的相关化合物:描述为HIV整合酶和HIV复制抑制剂的抑制剂,其中n是等于0,1,2或3的整数, 和R 1,R 3,R 4,R 12,R 14, ,R 16,R 30,R 32,R 34和R 36, 在本文中定义。 这些化合物可用于预防和治疗艾滋病毒感染以及艾滋病的预防,延迟发作和治疗。 这些化合物用作抗感染和艾滋病作为化合物本身或以药学上可接受的盐的形式。 化合物及其盐可以用作药物组合物中的成分,任选与其它抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。